↓ Skip to main content

Azithromycin for acute lower respiratory tract infections

Overview of attention for article published in Cochrane database of systematic reviews, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Azithromycin for acute lower respiratory tract infections
Published in
Cochrane database of systematic reviews, March 2015
DOI 10.1002/14651858.cd001954.pub4
Pubmed ID
Authors

Malinee Laopaiboon, Ratana Panpanich, Kyaw Swa Mya

Abstract

Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represents the most frequent cause of mortality, hospitalisation and medical consultation. Azithromycin is a macrolide antibiotic, structurally modified from erythromycin and noted for its activity against some gram-negative organisms associated with respiratory tract infections, particularly Haemophilus influenzae (H. influenzae).

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Brazil 1 2%
Unknown 64 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 21%
Researcher 12 18%
Other 9 14%
Student > Bachelor 7 11%
Unspecified 5 8%
Other 19 29%
Readers by discipline Count As %
Medicine and Dentistry 34 52%
Unspecified 7 11%
Nursing and Health Professions 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Agricultural and Biological Sciences 3 5%
Other 13 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2019.
All research outputs
#3,019,956
of 13,617,861 outputs
Outputs from Cochrane database of systematic reviews
#5,543
of 10,681 outputs
Outputs of similar age
#46,815
of 215,716 outputs
Outputs of similar age from Cochrane database of systematic reviews
#140
of 252 outputs
Altmetric has tracked 13,617,861 research outputs across all sources so far. Compared to these this one has done well and is in the 77th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,681 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 252 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.